What are the key drivers of the Next Generation Sequencing Sample Preparation market?

Advances in technology and increasing demand for genetic analysis are key drivers.

What are the major challenges facing the Next Generation Sequencing Sample Preparation market?

High costs and complexity of sample preparation are major challenges.

Which regions are leading the Next Generation Sequencing Sample Preparation market?

North America and Europe are leading the market due to high adoption rates.

Who are the top companies in the Next Generation Sequencing Sample Preparation market?

Illumina, Thermo Fisher, and Agilent are top companies in the market.

What are the future opportunities in the Next Generation Sequencing Sample Preparation market?

Emerging applications in precision medicine and cancer research offer future opportunities.

How is technology impacting the Next Generation Sequencing Sample Preparation market?

Advances in automation and artificial intelligence are improving sample preparation efficiency.

What is the current regulatory landscape for the Next Generation Sequencing Sample Preparation market?

Regulations vary by region, with FDA and EU guidelines shaping the market.

What is the future outlook for the Next Generation Sequencing Sample Preparation market?

The market is expected to experience significant growth due to increasing demand.

Next Generation Sequencing Sample Preparation Value Chain Analysis & Forecast Outlook 2033

Next Generation Sequencing Sample Preparation by Application (Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Agrigenomics & Forensics, Consumer Genomics, Epidemiology & Drug Development), by Types (NGS Library Preparation Kits, Semi-Automated Library Preparation, Automated Library Preparation, Clonal Amplification), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Next Generation Sequencing Sample Preparation Market Overview

The Next Generation Sequencing (NGS) Sample Preparation market refers to the process of preparing biological samples for sequencing. The Next Generation Sequencing Sample Preparation market size is estimated to be around $1.4 billion in 2025, with a growth outlook that is expected to drive the market forward. As the market forecast suggests, the industry is poised for significant expansion, with a compound annual growth rate (CAGR) of 12.1% from 2026 to 2033. The primary drivers of this growth include advancements in technology shifts, increasing demand for precision medicine, and the rising incidence of genetic disorders. The industry expansion is expected to be shaped by key forces such as regulatory requirements, competitive intensity, and consumer behavior.

Loading chart…

The largest region in the Next Generation Sequencing Sample Preparation market is North America, accounting for over 40% of the global market share. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing investments in genomics research and precision medicine. The market forecast suggests that the industry will continue to evolve, with key players focusing on innovation and strategic partnerships to drive growth. As the Next Generation Sequencing Sample Preparation market size continues to grow, it is expected to have a significant impact on the healthcare industry, enabling the development of personalized medicine and genetic testing.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; Myriad Genetics; Oxford Nanopore Technologies; Foundation Medicine; Genomatix GmbH; Illumina; Pacific Biosciences of California; Partek Incorporated; Perkin Elmer; PierianDx; QIAGEN; Quest Diagnostics Incorporated; Thermo Fisher Scientific; Congenica; DNASTAR; Eurofins Scientific; Roche; BGI; Bio-Rad Laboratories; Macrogen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Next Generation Sequencing Sample Preparation market is poised for significant growth, driven by advances in technology and increasing demand for genetic sequencing. The growth forecast for the Next Generation Sequencing Sample Preparation market size is expected to be substantial, with key drivers influencing the market's trajectory.

Growth Drivers2 items

Advances in next-generation sequencing technologies have led to increased efficiency and reduced costs, making genetic sequencing more accessible and driving growth in the Next Generation Sequencing Sample Preparation market.

The rising demand for precision medicine and personalized healthcare has created new opportunities for genetic sequencing, contributing to the growth of the Next Generation Sequencing Sample Preparation market size.

Restraints2 items

The high cost of next-generation sequencing equipment and reagents has limited adoption in some regions, restraining the growth of the Next Generation Sequencing Sample Preparation market.

The complexity of sample preparation protocols can be a barrier to entry for new market participants, limiting the growth forecast for the Next Generation Sequencing Sample Preparation market.

Opportunities2 items

The increasing use of next-generation sequencing in cancer research and diagnosis presents a significant opportunity for growth in the Next Generation Sequencing Sample Preparation market.

The development of new sample preparation technologies and methods has the potential to improve efficiency and reduce costs, driving growth in the Next Generation Sequencing Sample Preparation market size.

Challenges2 items

The next-generation sequencing industry faces challenges related to data analysis and interpretation, which can be a barrier to widespread adoption and impact the growth forecast for the Next Generation Sequencing Sample Preparation market.

The need for standardization in sample preparation protocols and technologies is a significant challenge that must be addressed to ensure the long-term growth and development of the Next Generation Sequencing Sample Preparation market.

Market Segmentation

Loading chart…

The Application segment of the Next Generation Sequencing Sample Preparation market is a crucial aspect of market taxonomy, as it determines the specific use cases for sample preparation products. This segment includes various applications such as whole-genome sequencing, targeted sequencing, and transcriptome sequencing, among others. Each application has its unique requirements for sample preparation, driving the demand for specific products and contributing to the overall market size. The Next Generation Sequencing Sample Preparation segmentation by application helps in understanding the diverse needs of end-users and identifying opportunities for growth.

The Types segment of the Next Generation Sequencing Sample Preparation market encompasses various subtypes, including DNA sequencing, RNA sequencing, and epigenetic sequencing, among others. Each subtype has its distinct sample preparation requirements, influencing the market size and growth. The types segment is critical in understanding the market taxonomy and identifying areas of focus for manufacturers and researchers. By analyzing the types segment, stakeholders can better comprehend the complexities of the Next Generation Sequencing Sample Preparation market and make informed decisions.

Next Generation Sequencing Sample Preparation Segmentation Breakdown14 items

Application

Oncology

Clinical Investigation

Reproductive Health

HLA Typing/Immune System Monitoring

Metagenomics

Agrigenomics & Forensics

Consumer Genomics

Epidemiology & Drug Development

Types

NGS Library Preparation Kits

Semi-Automated Library Preparation

Automated Library Preparation

Clonal Amplification

Regional Insights

Loading chart…

The Next Generation Sequencing Sample Preparation market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of next-generation sequencing technologies, favorable policies, and significant investments in the healthcare and research sectors.

Key drivers for each region include: for North America, ecosystem maturity, high infrastructure investment, and a strong research base; for Europe, a well-established research ecosystem, favorable regulatory policies, and a high level of technological adoption; for Asia Pacific, increasing demographics and infrastructure development, rising investment in research and development, and growing adoption of next-generation sequencing technologies; for Latin America, growing investment in healthcare and research, increasing adoption of new technologies, and improving infrastructure; and for Middle East & Africa, rising investment in healthcare and research, growing adoption of new technologies, and improving policies and regulations.

The regional forecast suggests that Asia Pacific will experience the highest growth rate, driven by the increasing demand for next-generation sequencing sample preparation solutions. The Next Generation Sequencing Sample Preparation market growth in this region is expected to be driven by the growing need for advanced sequencing technologies, increasing investment in research and development, and improving infrastructure.

Competitive Landscape

The Next Generation Sequencing Sample Preparation market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Next Generation Sequencing Sample Preparation competitive landscape is characterized by high competition, with companies focusing on differentiating themselves through innovative products and services. Global players are expanding their presence in regional markets, while local companies are leveraging their understanding of local regulations and customer needs to compete effectively.

Companies in this market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are examples of this:

Agilent Technologies: regional expansion

Illumina: innovation pipeline

Oxford Nanopore Technologies: premium pricing

Thermo Fisher Scientific: vertical integration

QIAGEN: OEM tie-ups

Roche: local manufacturing

Key Next Generation Sequencing Sample Preparation Companies20 items

Agilent Technologies

Myriad Genetics

Oxford Nanopore Technologies

Foundation Medicine

Genomatix GmbH

Illumina

Pacific Biosciences of California

Partek Incorporated

Perkin Elmer

PierianDx

QIAGEN

Quest Diagnostics Incorporated

Thermo Fisher Scientific

Congenica

DNASTAR

Eurofins Scientific

Roche

BGI

Bio-Rad Laboratories

Macrogen

Market Ecosystem

The Next Generation Sequencing Sample Preparation ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development and delivery of innovative sample preparation solutions, which enable efficient and accurate next-generation sequencing. The ecosystem's boundaries are defined by the interactions between these participants, influencing how value flows through the ecosystem.

Raw material/component suppliers — provide critical reagents and materials

Technology providers — develop sample preparation technologies and platforms

OEMs / manufacturers — design and manufacture sample preparation instruments

System integrators / EPCs — integrate sample preparation systems with sequencing platforms

Distributors / channel partners — deliver sample preparation products to end users

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — utilize sample preparation solutions for research and diagnostic applications

In the Next Generation Sequencing Sample Preparation ecosystem, control points are influenced by technology providers, OEMs, and end users, who drive adoption and demand for innovative sample preparation solutions. Dependency risks arise from input constraints, such as the availability of high-quality reagents, and standards and approvals from regulatory bodies. Switching costs and partnerships between ecosystem participants can also impact the ecosystem's dynamics. Furthermore, interoperability requirements between different sample preparation systems and sequencing platforms can create bottlenecks. A thorough value chain analysis is essential to understand these complexities and identify opportunities for growth and optimization.

Recent Industry Insights

The Next Generation Sequencing Sample Preparation industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between Illumina and Guardant Health, have focused on advancing cancer diagnostics. Furthermore, mergers and acquisitions, like the acquisition of Qiagen by Thermo Fisher Scientific, have reshaped the industry landscape. Additionally, product launches, including the introduction of new library preparation kits, have improved sequencing efficiency and accuracy.

Regulatory changes, such as updates to the European Union's In Vitro Diagnostic Regulation, have also impacted the industry. A shift in consumer trends towards personalized medicine has driven demand for targeted sequencing solutions. Funding rounds, including investments in companies like 10x Genomics, have supported the development of innovative sequencing technologies, further propelling the growth of the Next Generation Sequencing Sample Preparation industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Next Generation Sequencing Sample Preparation market outlook. The market attractiveness is high due to the increasing adoption of next-generation sequencing technologies in research and diagnostic applications. The competitive intensity is moderate, with key players investing heavily in research and development to improve sample preparation workflows.

The long-term outlook for the market is promising, driven by the growing demand for genomic analysis and precision medicine. The innovation landscape is rapidly evolving, with advancements in automation and artificial intelligence expected to improve sample preparation efficiency. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions, which can impact the overall Next Generation Sequencing Sample Preparation market outlook.

11 items

1. Executive Summary

2. Next Generation Sequencing Sample Preparation Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Next Generation Sequencing Sample Preparation Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Next Generation Sequencing Sample Preparation Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oncology

6.1.2. Clinical Investigation

6.1.3. Reproductive Health

6.1.4. HLA Typing/Immune System Monitoring

6.1.5. Metagenomics

6.1.6. Agrigenomics & Forensics

6.1.7. Consumer Genomics

6.1.8. Epidemiology & Drug Development

6.2. Global Next Generation Sequencing Sample Preparation Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. NGS Library Preparation Kits

6.2.2. Semi-Automated Library Preparation

6.2.3. Automated Library Preparation

6.2.4. Clonal Amplification

6.3. Global Next Generation Sequencing Sample Preparation Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Next Generation Sequencing Sample Preparation Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Next Generation Sequencing Sample Preparation Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Next Generation Sequencing Sample Preparation Market Competition by Key Manufacturers

8.1. Global Next Generation Sequencing Sample Preparation Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Next Generation Sequencing Sample Preparation: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Agilent Technologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Myriad Genetics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Oxford Nanopore Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Foundation Medicine

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Genomatix GmbH

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Illumina

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Pacific Biosciences of California

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Partek Incorporated

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Perkin Elmer

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. PierianDx

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. QIAGEN

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Quest Diagnostics Incorporated

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Thermo Fisher Scientific

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Congenica

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. DNASTAR

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Eurofins Scientific

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Roche

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. BGI

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Bio-Rad Laboratories

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Macrogen

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Next Generation Sequencing Sample Preparation Market

Figure 4: Global Next Generation Sequencing Sample Preparation Market: Drivers

Figure 5: Global Next Generation Sequencing Sample Preparation Market: Challenges

Figure 6: Global Next Generation Sequencing Sample Preparation Market: Trends

Figure 7: Global Next Generation Sequencing Sample Preparation Market: Opportunity

Figure 8: Global Next Generation Sequencing Sample Preparation Market: Restraint

Figure 9: Global Next Generation Sequencing Sample Preparation Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Next Generation Sequencing Sample Preparation Market Value (USD Million) By Region

Figure 15: Global Next Generation Sequencing Sample Preparation Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Next Generation Sequencing Sample Preparation Market Value (USD Million) By Region

Figure 23: Global Next Generation Sequencing Sample Preparation Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Next Generation Sequencing Sample Preparation Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Next Generation Sequencing Sample Preparation Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Next Generation Sequencing Sample Preparation Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Next Generation Sequencing Sample Preparation Market Value (USD Million) By Region

Table 10: Global Next Generation Sequencing Sample Preparation Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Next Generation Sequencing Sample Preparation Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Next Generation Sequencing Sample Preparation Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Next Generation Sequencing Sample Preparation Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Agilent Technologies Basic Information And Sales Area

Table 31: Agilent Technologies. Products Portfolio

Table 32: Myriad Genetics Basic Information And Sales Area

Table 33: Myriad Genetics. Products Portfolio

Table 34: Oxford Nanopore Technologies Basic Information And Sales Area

Table 35: Oxford Nanopore Technologies. Products Portfolio

Table 36: Foundation Medicine Basic Information And Sales Area

Table 37: Foundation Medicine. Products Portfolio

Table 38: Genomatix GmbH Basic Information And Sales Area

Table 39: Genomatix GmbH. Products Portfolio

Table 40: Illumina Basic Information And Sales Area

Table 41: Illumina. Products Portfolio

Table 42: Pacific Biosciences of California Basic Information And Sales Area

Table 43: Pacific Biosciences of California. Products Portfolio

Table 44: Partek Incorporated Basic Information And Sales Area

Table 45: Partek Incorporated. Products Portfolio

Table 46: Perkin Elmer Basic Information And Sales Area

Table 47: Perkin Elmer. Products Portfolio

Table 48: PierianDx Basic Information And Sales Area

Table 49: PierianDx. Products Portfolio

Table 50: QIAGEN Basic Information And Sales Area

Table 51: QIAGEN. Products Portfolio

Table 52: Quest Diagnostics Incorporated Basic Information And Sales Area

Table 53: Quest Diagnostics Incorporated. Products Portfolio

Table 54: Thermo Fisher Scientific Basic Information And Sales Area

Table 55: Thermo Fisher Scientific. Products Portfolio

Table 56: Congenica Basic Information And Sales Area

Table 57: Congenica. Products Portfolio

Table 58: DNASTAR Basic Information And Sales Area

Table 59: DNASTAR. Products Portfolio

Table 60: Eurofins Scientific Basic Information And Sales Area

Table 61: Eurofins Scientific. Products Portfolio

Table 62: Roche Basic Information And Sales Area

Table 63: Roche. Products Portfolio

Table 64: BGI Basic Information And Sales Area

Table 65: BGI. Products Portfolio

Table 66: Bio-Rad Laboratories Basic Information And Sales Area

Table 67: Bio-Rad Laboratories. Products Portfolio

Table 68: Macrogen Basic Information And Sales Area

Table 69: Macrogen. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Next Generation Sequencing Sample Preparation Market Value (USD Million) By Region

Table 75: Global Next Generation Sequencing Sample Preparation Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Next Generation Sequencing Sample Preparation Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; Myriad Genetics; Oxford Nanopore Technologies; Foundation Medicine; Genomatix GmbH; Illumina; Pacific Biosciences of California; Partek Incorporated; Perkin Elmer; PierianDx; QIAGEN; Quest Diagnostics Incorporated; Thermo Fisher Scientific; Congenica; DNASTAR; Eurofins Scientific; Roche; BGI; Bio-Rad Laboratories; Macrogen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The high cost of next-generation sequencing equipment and reagents has limited adoption in some regions, restraining the growth of the Next Generation Sequencing Sample Preparation market.

The complexity of sample preparation protocols can be a barrier to entry for new market participants, limiting the growth forecast for the Next Generation Sequencing Sample Preparation market.

Opportunities2 items

The increasing use of next-generation sequencing in cancer research and diagnosis presents a significant opportunity for growth in the Next Generation Sequencing Sample Preparation market.

Challenges2 items

Market Segmentation

Loading chart…

Next Generation Sequencing Sample Preparation Segmentation Breakdown14 items

Application

Oncology

Clinical Investigation

Reproductive Health

HLA Typing/Immune System Monitoring

Metagenomics

Agrigenomics & Forensics

Consumer Genomics

Epidemiology & Drug Development

Types

NGS Library Preparation Kits

Semi-Automated Library Preparation

Automated Library Preparation

Clonal Amplification

Regional Insights

Loading chart…

Competitive Landscape

Agilent Technologies: regional expansion

Illumina: innovation pipeline

Oxford Nanopore Technologies: premium pricing

Thermo Fisher Scientific: vertical integration

QIAGEN: OEM tie-ups

Roche: local manufacturing

Key Next Generation Sequencing Sample Preparation Companies20 items

Agilent Technologies

Myriad Genetics

Oxford Nanopore Technologies

Foundation Medicine

Genomatix GmbH

Illumina

Pacific Biosciences of California

Partek Incorporated

Perkin Elmer

PierianDx

QIAGEN

Quest Diagnostics Incorporated

Thermo Fisher Scientific

Congenica

DNASTAR

Eurofins Scientific

Roche

BGI

Bio-Rad Laboratories

Macrogen

Market Ecosystem

Raw material/component suppliers — provide critical reagents and materials

Technology providers — develop sample preparation technologies and platforms

OEMs / manufacturers — design and manufacture sample preparation instruments

System integrators / EPCs — integrate sample preparation systems with sequencing platforms

Distributors / channel partners — deliver sample preparation products to end users

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — utilize sample preparation solutions for research and diagnostic applications

Recent Industry Insights

Analyst Overview

Table of Contents